Morgan Stanley’s Neurogene NGNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $7.39M | Sell |
|
|||||
|
2025
Q2 | $8.16M | Buy |
|
|||||
|
2025
Q1 | $3.35M | Sell |
|
|||||
|
2024
Q4 | $7.54M | Sell |
|
|||||
|
2024
Q3 | $15M | Sell |
|
|||||
|
2024
Q2 | $13.9M | Sell |
|
|||||
|
2024
Q1 | $26.3M | Sell |
|
|||||
|
2023
Q4 | $13.2M | Buy |
|
|||||
|
2023
Q3 | $425K | Sell |
|
|||||
|
2023
Q2 | $682K | Buy |
|
|||||
|
2023
Q1 | $575K | Buy |
|
|||||
|
2022
Q4 | $286K | Sell |
|
|||||
|
2022
Q3 | $379K | Sell |
|
|||||
|
2022
Q2 | $641K | Sell |
|
|||||
|
2022
Q1 | $1.27M | Buy |
|
|||||
|
2021
Q4 | $2.89M | Buy |
|
|||||
|
2021
Q3 | $4.32M | Sell |
|
|||||
|
2021
Q2 | $5.82M | Buy |
|
|||||
|
2021
Q1 | $4.26M | Sell |
|
|||||
|
2020
Q4 | $6.07M | Buy |
|
|||||
|
2020
Q3 | $2.31M | Buy |
|
|||||
|
2020
Q2 | $1.24M | Buy |
|
|||||
|
2020
Q1 | $707K | Buy |
|
|||||
|
2019
Q4 | $31K | Buy |
|
|||||
|
2019
Q3 | $5K | Buy |
|
|||||
|
2019
Q2 | $2K | Sell |
|
|||||
|
2019
Q1 | $4K | Buy |
|
|||||
|
2018
Q4 | $1K | Sell |
|
|||||
|
2018
Q3 | $20K | Buy |
|
|||||
|
2018
Q2 | $16K | Sell |
|
|||||
|
2018
Q1 | $1.25M | Buy |
|
|||||
|
2017
Q4 | $131K | Sell |
|
|||||
|
2017
Q3 | $224K | Buy |
|
|||||
|
2017
Q2 | $202K | Sell |
|
|||||
|
2017
Q1 | $340K | Sell |
|
|||||
|
2016
Q4 | $1.13M | Buy |
|
|||||
|
2016
Q3 | $169K | Buy |
|
|||||
|
2016
Q2 | $60K | Sell |
|
|||||
|
2016
Q1 | $525K | Sell |
|
|||||
|
2015
Q4 | $876K | Buy |
|
|||||
|
2015
Q3 | $101K | Buy |
|
|||||
|
2015
Q2 | $0 | Sell |
|
|||||
|
2015
Q1 | $6K | Buy |
|
|||||
|
2014
Q4 | $0 | Buy |
|